Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze MIRM stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate MIRM investment potential.

What is MIRM stock price today?

Get real-time MIRM stock price, historical data, and price charts on Financhill. Track MIRM performance with our advanced analysis tools.

Is MIRM a good investment?

Evaluate MIRM investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy MIRM stock?

To buy MIRM stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of MIRM?

View detailed market capitalization data and company valuation metrics for MIRM on our comprehensive analysis page.

What is the P/E ratio of MIRM?

Use our fundamental analysis tools to view MIRM P/E ratio and compare valuation metrics with industry peers.

What are MIRM earnings?

View MIRM earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Mirum Pharmaceuticals, Inc. Stock Predictions

Exxon and Chevron Have an Unlikely New Competitor

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

Buy

MIRM
Mirum Pharmaceuticals, Inc.

Last Price:

$91.09

Seasonality Move:

1.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Meet America's Newest $1B Unicorn

Mirum Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, Mirum Pharmaceuticals, Inc. has on average historically risen by 35.1% based on the past 6 years of stock performance.
Mirum Pharmaceuticals, Inc. has risen higher in 5 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 83.33%
Is Mirum Pharmaceuticals, Inc. Stock Undervalued?

The current Mirum Pharmaceuticals, Inc. [MIRM] share price is $91.05. The Score for MIRM is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
MIRM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Mirum Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Mirum Pharmaceuticals, Inc. has on average historically risen by 35.1% based on the past 6 years of stock performance.

Mirum Pharmaceuticals, Inc. Stock Rating

Buy

Mirum Pharmaceuticals, Inc. (MIRM) is a Buy

Is Mirum Pharmaceuticals, Inc. overpriced?

Mirum Pharmaceuticals, Inc. has risen higher in 5 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 83.33%

Mirum Pharmaceuticals, Inc. Stock Price History

Is MIRM stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

mirumpharma.com

52-Week Data

52-Week High:

93.70

52-Week Low:

36.88

Prediction Charts

Market Cap:

4.7B

Price in USD:

91.05

Volume:

336.1K

Beta:

1.23

Technical Analysis

SMA50:

74.35

SMA100:

73.84

SMA200:

61.39

52-Wk Change:

98.67%

Stock Predictions

Is Mirum Pharmaceuticals, Inc. stock public?

Yes, Mirum Pharmaceuticals, Inc. is a publicly traded company.
What is the Mirum Pharmaceuticals, Inc. stock quote today?

The Mirum Pharmaceuticals, Inc. stock price is 91.05 USD today.
How to buy Mirum Pharmaceuticals, Inc. stock online?

You can buy Mirum Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-26	80.64	79.26	80.65	78.65
Dec-29	79.22	80.21	80.46	77.99
Dec-30	79.80	78.85	80.14	78.24
Dec-31	79.10	78.99	80.14	78.95
Jan-5	77.12	75.56	77.50	73.82
Jan-6	75.08	76.46	76.65	74.40
Jan-7	77.00	81.98	83.75	76.74
Jan-8	82.07	81.60	82.69	79.84
Jan-9	82.01	86.57	86.79	81.62
Jan-12	85.62	89.50	90.08	82.00
Jan-13	90.34	90.44	91.80	88.38
Jan-14	90.76	90.65	91.41	89.50
Jan-15	90.99	92.32	92.54	85.98
Jan-16	93.70	91.05	93.70	90.86

Mirum Pharmaceuticals, Inc. Earnings

Mirum Pharmaceuticals, Inc. Earnings Report: Per Share Mirum Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Mirum Pharmaceuticals, Inc. Forecast Revenue Growth

Mirum Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Mirum Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $0.21 per share.

* Mirum Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.